Xiehe Yixue Zazhi (Mar 2024)

The Role of CEACAM1 in Metabolic Dysfunction-associated Steatotic Liver Disease

  • DONG Kaixuan,
  • CHEN Danni,
  • ZHENG Ya,
  • WANG Yuping,
  • GUO Qinghong

DOI
https://doi.org/10.12290/xhyxzz.2024-0035
Journal volume & issue
Vol. 15, no. 5
pp. 1117 – 1123

Abstract

Read online

Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), a transmembrane protein of the immunoglobulin superfamily, is involved in mediating cell adhesion, tissue metastasis, control of immune response, and metabolic homeostasis. Studies have shown that CEACAM1 protects the liver by promoting insulin clearance and preventing fat deposition. The down-regulation of the CEACAM1 expression level leads to a vicious cycle of insulin resistance and aggravates metabolic disorders. As CEACAM1 is critical in controlling metabolic dysfunction-associated steatotic liver disease (MASLD), stimulating its pathway or regulating its expression level might be a potential new therapeutic approach for MASLD. In this paper, therefore, we summarize the research progress of CEACAM1 in MASLD.

Keywords